Authors: Urska B. Ogrinc and Sabina Sencar
Published in: Italian Journal of Gynaecology and Obstetrics. 2017;29(1):19-25
1. NEW MINIMALLY INVASIVE OPTION
The principle of non-ablative Er:YAG laser has been widely adopted for treating various conditions associated with pelvic floor dysfunction. Lately it has also been used to treat pelvic organ prolapse (POP). Since surgical treatments often come with the cost of long downtime and a high possibility of adverse events, developing alternative minimally invasive treatments is of a great importance.
2. METHODOLOGY
61 patients with grade II-IV cystoceles were treated 2-5 times at 2-month intervals. Prolapses were photographed and graded using the Barden-Walker scale.
3. EXCELLENT RESULTS
95% of the patients showed a reduction of at least one grade, 85% of which had achieved grade 0 or I, and 15% achieved grade II. 90% of the patients were very satisfied or satisfied with the treatment. No major adverse effects were noted.
4. PROLAPLASE® IS A BREAKTHROUGH, MINIMALLY INVASIVE OPTION FOR PATIENTS WITH POP
Clinical research supports the efficacy of the ProlapLase® treatment. With additional studies this innovative procedure may become a well-recognized minimally invasive alternative to surgery.
The effect of ProlapLase® on cystocele grade distribution at baseline and follow-ups.
